SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : SYNSORB (T.SYB)(SYBBF) CURE FOR CANCER? -- Ignore unavailable to you. Want to Upgrade?

To: Tupulak who wrote (68)8/6/1999 12:44:00 PM
From: John Trudeau  Respond to of 164
 
Curtis, that's a reasonable way to play SYB if you like their products/mgmt. IMO, they're both spec plays, and Oncolytics has more pizzaz than SYB... an important factor when it comes to spec plays.

Best of luck,

JT



To: Tupulak who wrote (68)8/6/1999 7:58:00 PM
From: richard wilson  Read Replies (1) | Respond to of 164
 
I am in for the long haul, but I think we will see a nice spike this fall/winter when they start the clinical trials of reovirus in Calgary, Alberta. I think we will hit $5 after the announcement and the associated press, then we will drift up and down for a while until the results of the trials start flowing.

What I hear, this thing has great potential.

Good trading,
Richard.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News